State of Tennessee, Department of Treasury’s iTeos Therapeutics ITOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-14,260
Closed -$156K 1683
2023
Q3
$156K Sell
14,260
-1,877
-12% -$24K ﹤0.01% 1519
2023
Q2
$214K Buy
16,137
+1,625
+11% +$23.2K ﹤0.01% 1591
2023
Q1
$198K Sell
14,512
-1,048
-7% -$18.8K ﹤0.01% 1544
2022
Q4
$304K Buy
15,560
+1,468
+10% +$28.7K ﹤0.01% 1458
2022
Q3
$269K Sell
14,092
-72
-0.5% -$1.66K ﹤0.01% 1466
2022
Q2
$292K Buy
14,164
+797
+6% +$18.9K ﹤0.01% 1460
2022
Q1
$430K Buy
+13,367
New +$486K ﹤0.01% 1444

Other funds holding ITOS

State of Tennessee, Department of Treasury's ITOS Position: Q4 2023 in Review

State of Tennessee, Department of Treasury sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 14,260 shares — an estimated $156K sold.

State of Tennessee, Department of Treasury first reported a position in ITOS in Q1 2022 and held it in 7 quarters. The position peaked at $430K in Q1 2022. 138 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

  • State of Tennessee, Department of Treasury reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 14,260 iTeos Therapeutics shares in Q4 2023, an estimated $156K.
  • State of Tennessee, Department of Treasury first reported a position in iTeos Therapeutics in Q1 2022 and held it in 7 quarters.
  • State of Tennessee, Department of Treasury's iTeos Therapeutics position peaked at $430K in Q1 2022.
  • 138 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on State of Tennessee, Department of Treasury's 13F filing for Q4 2023, filed 14 Feb 2024.